Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma-Reference-Cited by-同舟云学术

Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma

Published:2007-11 Issue:11 Volume:22 Page:1929-1935
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:J Gastroenterol Hepatol

Author:

Kuzuya Teiji,Katano Yoshiaki,Kumada Takashi,Toyoda Hidenori,Nakano Isao,Hirooka Yoshiki,Itoh Akihiro,Ishigami Masatoshi,Hayashi Kazuhiko,Honda Takashi,Goto Hidemi

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1746.2006.04707.x/fullpdf

Reference27 articles.

1. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma

2. Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV

3. Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumors

4. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000

Cited by 107 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral therapy improves postoperative survival in elderly HBV-related HCC patients: a propensity score analysis;2024-07-27

2. Perioperative remedial antiviral therapy in hepatitis B virus-related hepatocellular carcinoma resection: How to achieve a better outcome;World Journal of Gastrointestinal Oncology;2024-05-15

3. Child–Pugh grade deterioration stratified by the etiology after transcatheter arterial chemoembolization as initial treatment for hepatocellular carcinoma;Scientific Reports;2024-02-14

4. Persistently Elevated HBV Viral-Host Junction DNA in Urine as a Biomarker for Hepatocellular Carcinoma Minimum Residual Disease and Recurrence: A Pilot Study;Diagnostics;2023-04-25

5. Perioperative remedial antiviral therapy in HBV-related HCC resection: how to get a better outcome;2023-02-10